ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,463.54
0.08%
US Tech 100
18,558.00
0.21%
Dow Jones
40,539.93
-0.12%
Brent Oil
79.145
-1.77%
Bitcoin
67,181.80
-0.91%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Alto Neuroscience Inc (ANRO) Quote

Alto Neuroscience Inc

Alto Neuroscience Inc (ANRO)

NYSE
13.52
-0.84
(-5.85%)
At close: July 29 4:00PM
Delayed by 15 minutes
13.52
0.00
( 0.00% )
After Hours: 4:42PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
13.52
Bid
-
Ask
-
Volume
70,630
13.26 Day's Range 14.53
9.40 52 Week Range 24.00
Market Cap
363.472M
Previous Close
14.36
Open
14.49
Last Trade
3614
@
13.52
Last Trade Time
18:30:00
Financial Volume
$ 968,970
VWAP
13.719
Average Volume (3m)
111,536
Shares Outstanding
26,883,990
Dividend Yield
-
PE Ratio
-10.04
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-36.31M

About Alto Neuroscience Inc

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.altoneuroscience.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was $14.36. Over the last year, Alto Neuroscience shares have traded in a share price range of $ 9.40 to $ 24.00.

Alto Neuroscience currently has 26,883,990 shares outstanding. The market capitalization of Alto Neuroscience is $386.05 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -10.04.

ANRO Latest News

More News

Form 8-K - Current report

July 01 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 28 2024
Edgar (US Regulatory)

Form 8-K - Current report

April 25 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

April 23 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

April 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

April 10 2024
Edgar (US Regulatory)

Form 8-K - Current report

April 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

April 04 2024
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

April 02 2024
Edgar (US Regulatory)

Collective Audience Begins Trading Under New Nasdaq Ticker Symbol, CAUD

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Collective Audience, Inc. (Nasdaq:CAUD), a leading provider of digital consumer acquisition solutions, announced its common stock has commenced...

November 03 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.48-9.866666666671515.6513.267768314.71582101CS
42.927.306967984910.6217.5510.5312784914.19996473CS
12-0.85-5.9151009046614.3717.559.411153612.87782573CS
26-8.48-38.545454545522249.417555015.05286533CS
52-8.48-38.545454545522249.417555015.05286533CS
156-8.48-38.545454545522249.417555015.05286533CS
260-8.48-38.545454545522249.417555015.05286533CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BYONBeyond Inc
$ 14.70
(8.17%)
452.92k
SRFMSurf Air Mobility Inc
$ 0.3397
(7.64%)
2.18k
LGF.ALions Gate Entertainment Corp
$ 9.00
(5.14%)
18.08k
CTRICenturi Holdings Inc
$ 16.52
(5.09%)
368
STGSunlands Technology Group
$ 8.57
(5.02%)
7.02k
AIUMeta Data Limited
$ 4.02
(-11.65%)
167.74k
AEVAAeva Technologies Inc
$ 3.38
(-4.79%)
1.69k
FRGEForge Global Holdings Inc
$ 1.4105
(-4.70%)
7.42k
RNSTRenasant Corporation
$ 34.35
(-4.45%)
28.48k
CLVTClarivate PLC
$ 6.60
(-3.37%)
3.89k
SWSmurfit WestRock plc
$ 47.55
(0.00%)
4.8M
UBERUber Technologies Inc
$ 63.85
(0.14%)
3.95M
TAT&T Inc
$ 18.9016
(0.01%)
3.89M
JCIJohnson Controls International PLC
$ 69.30
(0.00%)
3.85M
BACBank of America Corporation
$ 41.1006
(0.03%)
2.83M

Discussion

View Full Feed
StayHumble StayHumble 3 minutes ago
Kramer NakedShorted✅4Bill+$DBMM shares 4Charity?✅✅✅


Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
https://investorshub.advfn.com/uimage/uploads/2023/1/29/hnfvkchart.png
DBMM
Denisk Denisk 3 minutes ago
here is what was in Holft emply,emt agreement
Definitions
. For purposes of this Agreement:
(i) “
Change in Control
” means:
(A) the sale of all or substantially all of the assets of the Company and its subsidiaries to one or more third parties in atransacti
AMRN
Lime Time Lime Time 3 minutes ago
We go to stock specific boards to talk about the stocks and only the stock, whether that be positive or negative. But we see political advertisement right where we click reply, or click to post. How is that such a thing, where politics aren't allowed on stock specific boards. "Do as we say, not as w
QuantumTravesty QuantumTravesty 3 minutes ago
Bud as many years as you’ve been in Hiru and he’s been with us you should know he does this on his 7/11 night shift salary as a public service.
Bless his heart.
HIRU
Poundthetable Poundthetable 3 minutes ago
Lake Ronkonkoma on Long Island is Bottomless too
SMCE
SloGin SloGin 3 minutes ago
Yeah quite entertaining a Quantum monkey and a Waterboy stuck in the 1990s!
HIRU
jonsmile jonsmile 4 minutes ago
161k is super low unfortunately no one had faith in Mangement
BMXI
Rizinup Rizinup 4 minutes ago
I agree, Screw the FDA while they keep jacking this around do the human trials in Europe or some 3rd world country, get the product to market and start saving/extending people’s lives globally all IMO
RDGL
Alpha14 Alpha14 4 minutes ago
The FOXO deal close yet?
FOXO
Tiger Money Tiger Money 4 minutes ago
It is a cure for mammals whom have cancerous tumors.
RDGL
al44 al44 4 minutes ago
In need of Bud Light treatment-

But the ban is a good first step
https://media.gettr.com/group7/getter/2024/07/29/10/c6a1defa-f7e0-c0c7-0f44-eb1f47ccfc83/6e01af021bd2603f779edc154761dd78_768x0.png
trademax42 trademax42 4 minutes ago
Don't know about a ceiling put on it. Momentum and news on fundamentals are driving this bus. In OTC, the bus slows down or reverses its acceleration if there is the fear of dilution followed by a RS. None of these fear exists at this time. imo

.0077 by Friday would be my max for Fr
HIRU
Whalatane Whalatane 4 minutes ago
Always good to have some bears on a board .....seriously .
I'm buying MU at roughly 30% of its high, expecting it may well hit $100 a share before it rebounds .

Kiwi
MU
IceCold8 IceCold8 5 minutes ago
We all have,some of us multiple times. Didn't you have a private audience with him,to answer shareholder questions???
CGAC
pumkin farmer pumkin farmer 5 minutes ago
Dude ,you follow 12000 OTC stocks ? amazing 🤔
RNVA
SloGin SloGin 5 minutes ago
Say what? What list Hiru on Euro exchanges? Where does it say that? He is saying he is advertising Hiru to European & Middle East Countries tradersto buy HIRU stock! Asking supporters on X not to glorify bashers posts with answers!
HIRU
Itchy palm Itchy palm 6 minutes ago
Empty podium empty head no different 😁
rogers711 rogers711 6 minutes ago
Has it not cured all the animals it has treated though?
RDGL
delerious1 delerious1 6 minutes ago
Post a tune or make a comment...
ipiros ipiros 6 minutes ago
Less clear than other tweets, true. What's up with the trade show link, is the Sheik in Vegas looking for another business venture?
HIRU
Taur1112 Taur1112 6 minutes ago
Great news today! Serious credibility, money and talent on board. This is going to go nuts soon.
MONI
ignatiusrielly35 ignatiusrielly35 7 minutes ago
Possible but I cannot imagine AVXL distributing a drug throughout Europe on its own.
AVXL
Runaway27 Runaway27 7 minutes ago
I realize that i may be screwed, blued and tattooed like most on this thread that are holding IV but what about UDF V, are they combining all or just concentrating on one of the issues, I've been holding 2700 shares of UDF V and only get a smidgeon of a dividend every 3 months which amounts to a Sam
Steady_T Steady_T 7 minutes ago
Eligibility request is the first step according to the EMU guidelines.
Steps involved in obtaining an
EU marketing authorisation
1. Submission of eligibility request.
(At the earliest 18 months and at the latest
7 months in advance of submission.)
2. Notific
AVXL

Your Recent History

NYSE
ANRO
Alto Neuroscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved